Blockade of [11C](+)-PHNO binding in human subjects by the dopamine D3 receptor antagonist ABT-925
Graff-Guerrero, Ariel, Redden, Laura, Abi-Saab, Walid, Katz, David A., Houle, Sylvain, Barsoum, Penny, Bhathena, Anahita, Palaparthy, Ramesh, Saltarelli, Mario D., Kapur, Shitij
Published in The international journal of neuropsychopharmacology (01.04.2010)
Published in The international journal of neuropsychopharmacology (01.04.2010)
Get full text
Journal Article
Safety and Efficacy of ABT-089 in Pediatric Attention-Deficit/Hyperactivity Disorder: Results from Two Randomized Placebo-Controlled Clinical Trials
Wilens, Timothy E., M.D, Gault, Laura M., M.D., Ph.D, Childress, Ann, M.D, Kratochvil, Christopher J., M.D, Bensman, Lindsey, B.S, Hall, Coleen M., M.S, Olson, Evelyn, B.S, Robieson, Weining Z., Ph.D, Garimella, Tushar S., Ph.D, Abi-Saab, Walid M., M.D, Apostol, George, M.D, Saltarelli, Mario D., M.D., Ph.D
Published in Journal of the American Academy of Child and Adolescent Psychiatry (01.01.2011)
Published in Journal of the American Academy of Child and Adolescent Psychiatry (01.01.2011)
Get full text
Journal Article
A Randomized, Double-Blind, Placebo-Controlled Phase 2 Study of α4β2 Agonist ABT-894 in Adults with ADHD
BAIN, Earle E, ROBIESON, Weining, PRITCHETT, Yili, GARIMELLA, Tushar, ABI-SAAB, Walid, APOSTOL, George, MCGOUGH, James J, SALTARELLI, Mario D
Published in Neuropsychopharmacology (New York, N.Y.) (01.02.2013)
Published in Neuropsychopharmacology (New York, N.Y.) (01.02.2013)
Get full text
Journal Article
A Randomized, Double-Blind, Placebo-Controlled Phase 2 Study of alpha 4 beta 2 Agonist ABT-894 in Adults with ADHD
Bain, Earle E, Robieson, Weining, Pritchett, Yili, Garimella, Tushar, Abi-Saab, Walid, Apostol, George, McGough, James J, Saltarelli, Mario D
Published in Neuropsychopharmacology (New York, N.Y.) (01.02.2013)
Published in Neuropsychopharmacology (New York, N.Y.) (01.02.2013)
Get full text
Journal Article
The scopolamine model as a pharmacodynamic marker in early drug development
Lenz, Robert A., Baker, Jeffrey D., Locke, Charles, Rueter, Lynne E., Mohler, Eric G., Wesnes, Keith, Abi-Saab, Walid, Saltarelli, Mario D.
Published in Psychopharmacologia (01.03.2012)
Published in Psychopharmacologia (01.03.2012)
Get full text
Journal Article
Adaptive, dose-finding phase 2 trial evaluating the safety and efficacy of ABT-089 in mild to moderate Alzheimer disease
Lenz, Robert A, Pritchett, Yili L, Berry, Scott M, Llano, Daniel A, Han, Shu, Berry, Donald A, Sadowsky, Carl H, Abi-Saab, Walid M, Saltarelli, Mario D
Published in Alzheimer disease and associated disorders (01.07.2015)
Published in Alzheimer disease and associated disorders (01.07.2015)
Get more information
Journal Article
A randomized pilot study of the efficacy and safety of ABT-089, a novel α4β2 neuronal nicotinic receptor agonist, in adults with attention-deficit/hyperactivity disorder
Bain, Earle E, Apostol, George, Sangal, R Bart, Robieson, Weining Z, McNeill, Dawnelle L, Abi-Saab, Walid M, Saltarelli, Mario D
Published in The journal of clinical psychiatry (01.06.2012)
Published in The journal of clinical psychiatry (01.06.2012)
Get more information
Journal Article
Divalproex Sodium Extended-Release for the Prophylaxis of Migraine Headache in Adolescents: Results of a Stand-Alone, Long-Term Open-Label Safety Study
Apostol, George, Lewis, Donald W., Laforet, Genevieve A., Robieson, Weining Z., Fugate, Julie M., Abi-Saab, Walid M., Saltarelli, Mario D.
Published in Headache (01.01.2009)
Published in Headache (01.01.2009)
Get full text
Journal Article
Efficacy and safety of the novel α4β2 neuronal nicotinic receptor partial agonist ABT-089 in adults with attention-deficit/hyperactivity disorder: a randomized, double-blind, placebo-controlled crossover study
Apostol, George, Abi-Saab, Walid, Kratochvil, Christopher J., Adler, Lenard A., Robieson, Weining Z., Gault, Laura M., Pritchett, Yili L., Feifel, David, Collins, Michelle A., Saltarelli, Mario D.
Published in Psychopharmacologia (01.02.2012)
Published in Psychopharmacologia (01.02.2012)
Get full text
Journal Article
A double-blind, randomized, placebo-controlled study of the dopamine D₃ receptor antagonist ABT-925 in patients with acute schizophrenia
Redden, Laura, Rendenbach-Mueller, Beatrice, Abi-Saab, Walid M, Katz, David A, Goenjian, Armen, Robieson, Weining Z, Wang, Yaqin, Goss, Sandra L, Greco, 4th, Nicholas, Saltarelli, Mario D
Published in Journal of clinical psychopharmacology (01.04.2011)
Published in Journal of clinical psychopharmacology (01.04.2011)
Get more information
Journal Article
ABT-089 demonstrates efficacy in a human model of cognition and good tolerability in subjects with Alzheimer's disease taking acetylcholinesterase inhibitors
Lenz, Robert A, Garimella, Tushar, Dutta, Sandeep, Locke, Charles, Baker, Jeffrey D, Wesnes, Keith, Maruff, Paul, Abi-Saab, Walid M, Saltarelli, Mario D
Published in Alzheimer's & dementia (01.07.2009)
Published in Alzheimer's & dementia (01.07.2009)
Get full text
Journal Article
ABT-089, a neuronal nicotinic receptor partial agonist, reverses scopolamine-induced cognitive deficits in healthy normal subjects
Baker, Jeffrey D, Lenz, Robert A, Locke, Charles, Wesnes, Keith, Maruff, Paul, Abi-Saab, Walid M, Saltarelli, Mario D
Published in Alzheimer's & dementia (01.07.2009)
Published in Alzheimer's & dementia (01.07.2009)
Get full text
Journal Article
A Randomized, Double-Blind, Placebo-Controlled Phase 2 Study of [alpha]4[beta]2 Agonist ABT-894 in Adults with ADHD
Bain, Earle E, Robieson, Weining, Pritchett, Yili, Garimella, Tushar, Abi-saab, Walid, Apostol, George, Mcgough, James J, Saltarelli, Mario D
Published in Neuropsychopharmacology (New York, N.Y.) (01.02.2013)
Published in Neuropsychopharmacology (New York, N.Y.) (01.02.2013)
Get full text
Journal Article
Rapid in vitro modulation of [3H]hemicholinium-3 binding sites in rat striatal slices
Saltarelli, M D, Lowenstein, P R, Coyle, J T
Published in European journal of pharmacology (03.03.1987)
Published in European journal of pharmacology (03.03.1987)
Get more information
Journal Article
Efficacy and safety of the novel [α.sub.4][β.sub.2] neuronal nicotinic receptor partial agonist ABT-089 in adults with attention-deficit/ hyperactivity disorder: a randomized, double-blind, placebo-controlled crossover study
Apostol, George, Abi-Saab, Walid, Kratochvil, Christopher J, Adler, Lenard A, Robieson, Weining Z, Gault, Laura M, Pritchett, Yili L, Feifel, David, Collins, Michelle A, Saltarelli, Mario D
Published in Psychopharmacology (01.02.2012)
Published in Psychopharmacology (01.02.2012)
Get full text
Journal Article
Efficacy and safety of the novel alpha sub(4) beta sub(2) neuronal nicotinic receptor partial agonist ABT-089 in adults with attention-deficit/hyperactivity disorder: a randomized, double-blind, placebo-controlled crossover study
Apostol, George, Abi-Saab, Walid, Kratochvil, Christopher J, Adler, Lenard A, Robieson, Weining Z, Gault, Laura M, Pritchett, Yili L, Feifel, David, Collins, Michelle A, Saltarelli, Mario D
Published in Psychopharmacology (01.02.2012)
Published in Psychopharmacology (01.02.2012)
Get full text
Journal Article